ARCHIVES

Abstracts Of Papers From Conference On Adjuvant Therapy

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

CCOP Applications Total 110(At Least), Plus 25 from Research Bases; All 57 Survivors Try Again

November 21, 1986

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

NCI Suggests 75 Topics for SBIR Proposals

October 4, 1985

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007